All News Articles

Showing 1 – 10 (of 178)
two smiling women post in a garden

Clinical Trials

December 02, 2022

Clinical trials coordinator Alexandria Green falls in love with all her patients. But she's formed a particularly strong bond with one in particular.

illustration of closeup of HPV

Rising Rates

November 28, 2022

South Carolina is seeing one of the fastest rises in anal cancer incidence among women and anal cancer mortality among men.

computer monitor showing image of a lung cancer scan

Lung Cancer Screening

November 22, 2022

For lung cancer screening to work, people need to get scans every year. But a new study shows people don't return for repeat scans.

illustration of a holographic no smoking symbol emanating from a cell phone

Smoking Cessation E-visits

November 16, 2022

People in rural areas are more likely to smoke and less likely to quit. A Hollings psychologist is using e-visits to reach these smokers and help them to quit.

Ronald Teufel, II, M.D. (left) in conversation with Andrew Atz, M.D. (right)

Pediatric Covid Treatment

November 16, 2022

A study conducted at 42 children’s hospitals showed a lower-than-expected compliance rate with recently released guidelines for COVID-19 care.

Closeup of white man's hands. He's wearing camouflage.

PTSD Relief

October 19, 2022

Veteran who tried technology-based treatment for PTSD in clinical trial at MUSC says it made “night and day difference.”

STEM-CREW team members. From the left: Rachel Simmons, coordinator; Angela Passarelli, Ph.D., coaching director; Carol Feghali-Bostwick, Ph.D., principal investigator; Jesse Goodwin, Ph.D., chief innovation officer; and Tammy Loucks, SCTR science development officer

Women Entrepreneurs

October 18, 2022

Initiative aims to increase the number of women entrepreneurs by offering coaching, mentoring and training to senior postdoctoral fellows and junior faculty.

3-D transparent rendering of internal organs with the colon in red

Colonoscopy Recommendations

October 13, 2022

Doctors at MUSC Hollings Cancer Center say that colonoscopies remain an important screening tool, question results of recent study.

Immunofluorescence images showing healthy (left) and scleroderma  (right) lung. The scleroderma  lung shows reduced levels of Cathepsin L (green) and increased levels of fibroblast activation marker.

Cathepsin L in Scleroderma

September 29, 2022

MUSC researchers show that patients with scleroderma and lung fibrosis, or scarring, have too little of the antifibrotic protein Cathepsin L.

a man in a doctor's white coat with stethoscope around his neck poses in a clinic hallway

Circulating ctDNA

September 21, 2022

A pilot study will measure circulating tumor DNA in cancer patients with 'extraordinary' response to immunotherapy.

Showing 1 – 10 (of 178)